Geisinger CEO hired by Google to oversee healthcare push

Amy Baxter | | Health Exec |

Google has taken another prominent healthcare executive under its roof to oversee the company’s own healthcare initiatives, The Wall Street Journal reported.

David Feinberg, MD, who has served as president and CEO of Geisinger Health System since 2015, has been named to a newly created leadership role at Google. Geisinger, based in Danville, Pennsylvania, is a healthcare system that operates 13 hospital campuses and a health plan with nearly 600,000 members. It serves more than 1.5 million patients in Pennsylvania and New Jersey.

Jaewon Ryu, MD, JD, will act as interim president and CEO of Geisinger starting Dec. 1, 2018, Geisinger announced.

Google’s latest hire continues the company’s emergence in the healthcare space. Google is reportedly working on an AI-powered wellness app, among other initiatives. Google’s parent company Alphabet has also invested hundreds of millions of dollars in healthcare startups, including health insurer Oscar Health.

Feinberg will help provide strategic direction for Google's ongoing healthcare pushes, the WSJ reported. 

See the full story below:

Google Picks Geisinger CEO to Oversee Health-Care Initiatives

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Cardiovascular Business
American Heart Association highlights importance of NIH as battle over Trump funding cuts continues

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

Cardiovascular Business
Cardiologist questions FDA’s approval process for high-risk medical devices

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

Cardiovascular Business
FDA announces new recall of Johnson & Johnson heart pumps over safety concerns

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”